The global extracorporeal membrane oxygenation market was valued at US$ 546.73 million in 2021 and is projected to reach US$ 677.64 million by 2028. The market is estimated to grow at a CAGR of 3.1% during 2022–2028.
Extracorporeal membrane oxygenation (extracorporeal membrane oxygenation) is a treatment used for blood circulation through an artificial lung. The system helps provide heart-lung bypass route outside the body. This also provides support to patients who need a lung transplant. The extracorporeal membrane oxygenation market growth is attributed to the rising prevalence of cardiovascular diseases and respiratory failures and the growing adoption of extracorporeal membrane oxygenation in lung transplantation procedures. However, complications associated with extracorporeal membrane oxygenation hinder the growth of the market.
Download sample PDF Copy at: https://www.theinsightpartners.com/sample/TIPHE100001219/
Terumo Group, Medtronic Plc, MicroPort Scientific Corporation, LivaNova Plc, Nipro Medical Corporation, Eurosets S.R.L., Getinge AB, Braile Biomedica, Fresenius Medical Care AG & Co KGaA, and Abiomed Inc are among the leading companies operating in the extracorporeal membrane oxygenation market.
The global extracorporeal membrane oxygenation market, based on modality, is segmented into venoarterial extracorporeal membrane oxygenation, venovenous extracorporeal membrane oxygenation, and arteriovenous extracorporeal membrane oxygenation. In 2021, the venoarterial extracorporeal membrane oxygenation segment held the largest market share. Moreover, the same segment is anticipated to register the highest CAGR from 2022 to 2028, owing to its high usage in treating patients affected by cardiac arrest by assisting with algorithm life support strategies to restore blood circulation. Veno-arterial extracorporeal membrane oxygenation (VA-extracorporeal membrane oxygenation) has been widely used over the last decade. It is an effective and valuable therapeutic option in refractory cardiogenic shock of various etiologies.
The growing cases of COVID-19 have propelled the demand for extracorporeal membrane oxygenation systems across the world. India, China, and other developing nations in the region were among the worst-affected economies. These countries have a significant geriatric population, which is highly susceptible to novel coronavirus infection. The health condition of aged COVID-19 patients who have diabetes, cardiovascular diseases, high blood pressure, and other chronic disorders is generally critical. extracorporeal membrane oxygenation plays a vital role in COVID-19 treatment. Therefore, the demand for extracorporeal membrane oxygenation systems is increasing in such countries. As a result, companies operating in the extracorporeal membrane oxygenation market witnessed a positive impact of the COVID-19 pandemic.
Inquiry Before Buying at: https://www.theinsightpartners.com/inquiry/TIPHE100001219/
Based on modality, the extracorporeal membrane oxygenation market is segmented into venoarterial extracorporeal membrane oxygenation, venovenous extracorporeal membrane oxygenation, and arteriovenous extracorporeal membrane oxygenation. Based on application, the market is bifurcated into cardiology and respiratory. In terms of age group, the global extracorporeal membrane oxygenation market is segmented into neonates, pediatrics, and adults. By geography, the global market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
The report highlights the key factors driving the market and prominent players’ developments. The market growth is primarily attributed to the rising prevalence of cardiovascular diseases and respiratory failures and the growing adoption of extracorporeal membrane oxygenation in lung transplantation procedures. However, complications associated with extracorporeal membrane oxygenation hamper the market growth.
Growing Adoption of extracorporeal membrane oxygenation in Lung Transplantation Procedures Drive extracorporeal membrane oxygenation Market Growth
Lung transplantation is a life-saving treatment option for patients suffering from end-stage lung diseases, such as COPD, Idiopathic pulmonary fibrosis (IPF), and cystic fibrosis, to improve the quality of life. extracorporeal membrane oxygenation is a versatile tool used in all lung transplantation phases, such as preoperative, intraoperative, and postoperative periods. It acts as a bridge for patient undergoing lung transplantation. Therefore, the adoption of extracorporeal membrane oxygenation during lung transplantation is growing rapidly to manage patients with life-threatening lung disease. According to the Scientific Registry of Transplant Recipients (SRTR), ~4,600 lung transplants are performed across the world every year, of which 55% were performed in North America. According to the same source, ~2,759 patients underwent lung transplantation, and ~3,243 patients were added to the lung transplant waiting list in the US. Primary graft dysfunction (PGD) is the leading cause of death after a lung transplant. Thus, extracorporeal membrane oxygenation is used penultimately in treating PGD post lung transplantation. According to National Library Medicine (NLM), in 2022, the overall incidence of PGD is 30%, in which the risk factors include preoperative donor lung ischemia, organ acquisition, preservation techniques, and intraoperative organ implantation and reperfusion. Thus, the demand for extracorporeal membrane oxygenation equipment is growing for treating patients suffering from PGD.
Purchase a Copy of this Report: https://www.theinsightpartners.com/buy/TIPHE100001219/
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi